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Apoptosis is involved in the regulation of Schwann cell numbers
during normal development and after axonal damage, but the
molecular regulation of Schwann cell death remains unknown.
We have used stably transfected rat Schwann cell lines to study
the potential roles of nerve growth factor (NGF), the antiapop-
totic protein Bcl-2 and the cytokine response modifier A (CrmA)
in modulating Schwann cell death in vitro. Bcl-2 inhibited
Schwann cell apoptosis induced by survival factor withdrawal,
whereas CrmA did not. In contrast, Bcl-2-transfected Schwann
cells were susceptible to apoptosis in response to exogenous
NGF, whereas CrmA-expressing cell lines were resistant. Dem-
onstration of high levels of the low-affinity neurotrophin recep-
tor p75 but not the high-affinity TrkA receptor on the Bcl-2-
transfected cell lines suggested that the NGF-induced killing
was mediated by p75. This was confirmed by resistance of
Schwann cells isolated from p75 knockout mice to the NGF-
induced cell death. Nerve growth factor also promoted the
death of wild-type mouse and rat Schwann cells in the absence
of survival factor withdrawal. Endogenous Bcl-2 mRNA was
expressed by wild-type Schwann cells in all conditions that
promoted survival but was downregulated to undetectable lev-
els after survival factor withdrawal. In conclusion, our results
demonstrate the existence of two separate pathways that ex-
pedite apoptosis in Schwann cells: a Bcl-2-blockable pathway
initiated on loss of trophic support, and a Bcl-2-independent,
CrmA-blockable pathway mediated via the p75 receptor.
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The number of Schwann cells in peripheral nerve is tightly
regulated, and programmed cell death, or apoptosis, has been
implicated in this process (Syroid et al., 1996; Trachtenberg and
Thompson, 1996). Axonally derived neuregulins prevent Schwann
cell apoptosis, suggesting that Schwann cell numbers are controlled
by competition for axonally derived trophic support (Grinspan et
al., 1996). However, the molecules involved in mediating Schwann
cell apoptosis are unknown.
Apoptosis involves activation of a cascade of proteolytic en-
zymes called caspases (Nicholson and Thornberry, 1997). Mem-
bers of the Bcl-2 protein family are key regulators of apoptosis
and are categorized according to their ability to promote (e.g.,
Bak, Bax, Bik) or inhibit (e.g., Bcl-2, Bcl-xL, Bcl-w) apoptosis
(Newton and Strasser, 1998). The mechanism of the anti-
apoptotic function of Bcl-2 is uncertain, but Bcl-2 proteins regu-
late the activation of key caspases (Adams and Cory, 1998;
Newton and Strasser, 1998). Recently, it was suggested that Bcl-2
could also serve as a caspase substrate, such that activation of the
cell surface receptor Fas (Itoh et al., 1991) leads to cleavage of
Bcl-2, which then accelerates rather than inhibits apoptosis
(Cheng et al., 1997).
Schwann cells express high levels of the low-affinity neurotro-
phin receptor p75 (Lemke and Chao, 1988), which has sequence
similarity to the tumor necrosis factor receptor (TNFR) p55TNFR
and to Fas (Meakin and Shooter, 1992). Ligand binding to Fas or
p55TNFR initiates programmed cell death via activation of
caspase 8, which can cleave other caspases. This caspase
8-mediated pathway cannot be blocked by Bcl-2 but is inhibitable
by a poxvirus caspase inhibitor, cytokine response modifier A
(CrmA) (Chinnaiyan et al., 1995; Strasser et al., 1995; Cohen,
1997). A role for p75 in signaling the death of neural cells has also
been established (Rabizadeh et al., 1993; Barrett and Bartlett,
1994; Frade et al., 1996; Frade and Barde, 1998), but the role of
ligand binding in p75 activation is uncertain. In some systems, p75
induces cell death constitutively (Rabizadeh et al., 1993), whereas
cell death can also be induced by p75 activation through ligand
binding (Casaccia-Bonnefil et al., 1996; Frade et al., 1996). The
intracellular death pathway initiated by p75 signaling is unknown.
The neurotrophins not only bind to p75 but also bind with high
affinity to receptor tyrosine kinases known as Trks, comprising
Trk-A, -B, and -C (Kaplan et al., 1991; Kaplan and Miller, 1997).
Potential mechanisms by which the prototypic neurotrophin,
nerve growth factor (NGF), signals were recently assessed in
oligodendrocytes; it was suggested that activation of Trk-A pro-
moted survival via activation of NF-kB and via suppression of a
death signal delivered by p75, acting through c-jun kinase (Yoon
et al., 1998). It is of note that Schwann cells express only low
levels of the Trk receptors (Yamamoto et al., 1993).
The role of p75 in Schwann cells is obscure. Schwann cells
could possibly bind and present NGF to regenerating neurons
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after peripheral axotomy (Heumann et al., 1987), and it has been
suggested that NGF could support Schwann cell migration (An-
ton et al., 1994). There is no compelling evidence, however, to
indicate a role for NGF as a Schwann cell survival factor, al-
though NGF can activate NF-kB through p75 (Carter et al.,
1996). To date, cell death signaling through p75 has not been
demonstrated in Schwann cells.
In this study, using stably transfected Schwann cell lines, we
found that Bcl-2, but not CrmA, protects Schwann cells from
apoptosis induced by survival factor withdrawal. In contrast,
Schwann cells transfected with Bcl-2 were sensitive to apoptosis
in response to exogenous NGF, whereas CrmA-transfected
Schwann cells were resistant. Lack of TrkA expression in the
Bcl-2-transfected cell lines and resistance of p75-deficient
Schwann cells to NGF-induced killing suggested that the NGF-
induced death response was mediated via the p75 receptor.
MATERIALS AND METHODS
Cell culture and transfections. Cultures of rat Schwann cells were prepared
from postnatal day 3 sciatic nerve and purified to .99.5% homogeneity
as described previously (Brockes et al., 1979). Cells were plated on
poly-L-lysine-coated (100 mg/ml; Sigma, St. Louis, MO) 10 cm tissue
culture Petri dishes or 6-well plates (Falcon) and maintained in DMEM
(Life Technologies, Gaithersburg, MD), 10% fetal calf serum (FCS)
(HyClone, Logan, UT), 2 mm forskolin (Sigma), and 10 ng/ml recombi-
nant human neuregulin-b (Amgen, Thousand Oaks, CA). Subconfluent
cultures that had been passaged 5–10 times were transfected either by
using the transfection reagent LipofectAMINE (Life Technologies)
according to the manufacturer’s instructions or by electroporation of 2 3
10 7 Schwann cells suspended in 500 ml of PBS, at 270 V and 960 mFD,
with 10 mg of plasmid cDNA containing either full-length human Bcl-2 or
poxvirus CrmA cloned into the pEF FLAGpGKpuro (pEF) mammalian
expression vector (Huang et al., 1997). This vector contains sequences
encoding a Flag-tag and puromycin resistance. Both the Bcl-2 and CrmA
plasmid cDNAs were kind gifts from Dr. David Vaux (The Walter and
Eliza Hall Institute of Medical Research). Puromycin (Sigma) was added
to facilitate positive selection at 2 mg/ml 48 hr after transfection.
Mouse Schwann cells were isolated from postnatal day 2 sciatic nerves
of BALB/c mice and homozygous mutant mice deficient for p75 (Lee et
al., 1992) backcrossed onto the BALB/c and 129 genetic background.
Briefly, nerves were digested for 30 min at 37°C by incubation with 0.25%
trypsin (Sigma) and 0.02% collagenase (Sigma) in HBSS. Digestion was
terminated by addition of 10% ice-cold FCS. Single-cell suspensions
were subsequently prepared by passage of the cells through 18, 21, and 23
gauge needles fitted to a 1 ml syringe. Cells were then pelleted, washed
once with DMEM/10% FCS, and plated on 96-well plate wells in
DMEM containing 10% FCS and 10 ng/ml of neuregulin-b. Cells were
expanded for 5–7 d and then sorted using rat anti-mouse Thy 1.2 antibody
(Ab) (103 concentrated supernatant of hybridoma 30H12) and rabbit
complement (Life Technologies) to remove contaminating fibroblasts.
Sorted cells were washed and plated on poly-L-lysine-coated 24-well plate
wells and then subsequently dissociated on the following day to set up
viability assays (see below). The percentage of Schwann cells in both the
wild-type and knockout cultures was determined after sorting by S-100
staining of cells plated on 8-well chamber slides. A total of 500 cells/
culture were counted from six to seven separate fields at 403 magnifi-
cation, yielding purities of 94 6 2% for the wild-type cultures and 96 6
3% for the p75 knockout cultures.
Growth factors. The b-form of recombinant human neuregulin was
obtained from Amgen. Nerve growth factor, purified from male mouse
submaxillary glands (mNGF 2.5S; Alomone Labs), was purchased from
Sapphire Bioscience (Alexandria, NSW, Australia). Recombinant human
insulin-like growth factor (IGF-1) was purchased from Boehringer
Mannheim.
Figure 1. Intracellular expression of the human Bcl-2 protein and the poxvirus caspase inhibitor CrmA in the transfected rat Schwann cell lines Bcl-2#1,
-#3, -#4, and CrmA#7, #14, and #15. Immunofluorescence staining was performed with the mouse mAb Bcl-2–100 against the human Bcl-2 (for the
Bcl-2 cell lines) or with mouse anti-Flag mAb (for the CrmA cell lines), and binding of primary antibody was detected with FITC-conjugated sheep
anti-mouse IgG. As negative controls, rat Schwann cells transfected with the empty expression plasmid pEF were similarly stained (indicated in the
histograms with a dashed line).
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Antibodies and flow cytometry reagents. Monoclonal antibody to the
low-affinity nerve growth factor receptor of rat (clone MC192) and a
monoclonal antibody to mouse nerve growth factor (clone 27/21, which
also reacts with NGF from rat) were purchased from Boehringer Mann-
heim. Anti-Flag Ab (clone M2 ) was from Sigma (NSW, Australia).
Anti-human Bcl-2 Ab that was used for flow cytometry (DAKO-Bcl-2,
clone 124) and rabbit anti-cow-S-100 antibody were from Dako Corpo-
ration (Carpinteria, CA). Anti-human Bcl-2 Ab [Bcl-2–100 (Pezzella et
al., 1990)] that was used for Western blotting was a kind gift from Dr.
David Huang (The Walter and Eliza Hall Institute of Medical Research).
Anti-human CD40L monoclonal antibody (mAb; isotype control for the
MC192 mAb) was from PharMingen (San Diego, CA). FITC-conjugated
sheep anti-mouse IgG and FITC-conjugated goat anti-mouse IgG
(Southern Biotechnology Associates, Birmingham, AL) were purchased
from Silenius Laboratories (Victoria, Australia). Annexin-V-Fluos re-
agent, a fluorescence-conjugated anticoagulant for the detection of phos-
phatidylserine on the outer leaflet of apoptotic cells, was purchased from
Boehringer Mannheim.
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide survival as-
say. To assess the survival kinetics of the various transfected rat Schwann
cell lines, the cells were first trypsinized and washed three times with
ice-cold DMEM. Washed cells were then plated at 4 3 10 4 cells/ml in
either DMEM without serum and without growth factors or with
DMEM together with either 1, 10, or 100 ng/ml NGF, with 500 ng/ml
anti-mouse NGF antibody, or 10 ng/ml NGF together with 500 ng/ml
anti-NGF. Assays were performed over a 72 hr period in multiple
Terasaki microwell plates, such that numbers of viable 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT)-positive
cells were counted at 0, 24, 48, and 72 hr. Six wells for each time point
and each condition were assessed. Cells exhibiting a blue granular
reaction product 1 hr after addition of 0.5 mg/ml MTT were counted as
positive. The percentage of surviving cells was then determined as a
fraction of the baseline cell count for each experimental condition.
Wild-type rat and mouse Schwann cells were similarly assessed, in either
DMEM alone, DMEM together with 10 ng/ml NGF and, in a subset of
experiments, 100 ng/ml IGF-1 and 50 ng/ml neuregulin-b with or without
10 ng/ml NGF. Because of the limited numbers of mouse Schwann cells,
only baseline and 48 hr time points were included.
Statistics. Statistical significance of the differences in survival between
Bcl-2 and CrmA-transfected and control cell lines for each of the culture
conditions tested was assessed using unpaired Student’s t test, with the
aid of Microsoft Excel Version 4.0 computer software and the Student
Distribution from Geigy Scientific Tables. p values ,0.05 were taken as
statistically significant.
S-100 immunohistochemistry. To analyze for expression of the glial
protein S-100, Schwann cells were cultured on 8-well Chamber slides
(Nunc, Roskilde, Denmark). The cultures were then fixed with 4%
paraformaldehyde and stained with rabbit anti-cow S-100 antibody at
1:200 dilution. Binding of the primary antibody was detected using a
Vectastain peroxidase anti-rabbit IgG kit according to the manufactur-
er’s instructions. A chromogenic reaction was developed with DAB, and
the slides were mounted in Gurr’s Aquamount (BDH Laboratory Sup-
Figure 2. The transfected Schwann cells express the astroglial protein
S-100. Immunoperoxidase staining of Bcl-2#1 cells ( B) and CrmA#14-
cells (C) with rabbit anti-cow-S-100 protein is shown. As negative con-
trols, the same cell lines were stained with secondary antibody only, as
shown for the Bcl-2#1 cell line in A. Scale bar (shown in A): A, B, 50 mm;
C, 100 mm.
Figure 3. Northern blot analysis confirms that the Bcl-2-transfected cell
lines express transcripts of the Schwann cell-specific P0 gene. Shown is P0
expression of the three Bcl-2-transfected cell lines cultured in either high
(20 mM, lanes 1–3) or low concentration of forskolin (2 mM, Bcl-2#1 cell
line, lane 4 ). Lane 5 contains fibroblast RNA as a negative control, and
lane 6 contains wild-type rat Schwann cell RNA as a positive control.
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plies, Poole, UK), coverslipped, and photographed using Ektachrome
200 ASA color slide film.
Flow cytometry. To determine whether the transfected Schwann cell
lines expressed the human Bcl-2 protein intracellularly, the cells were
stained with anti-human Bcl-2 Ab as described previously (Strasser et al.,
1995). Intracellular expression of CrmA protein from the CrmA plasmid
was indirectly assessed by staining transfected cells with anti-Flag anti-
bodies, using a similar protocol. Cell surface expression of p75 was
determined by incubating the cells for 30 min on ice with 1 mg/ml mouse
mAb clone 192 against rat p75, or with isotype-matched control mAb
(anti-human CD40L). The cells were then washed twice with PBS con-
taining 2% FCS and 0.1% sodium azide, incubated for an additional 30
min with FITC-conjugated sheep anti-mouse IgG, washed twice, and
analyzed using a FACScan flow cytometer (Becton Dickinson, Mountain
View, CA).
To distinguish between apoptosis and necrosis, the pEF-1 and the
Bcl-2#1 transfected Schwann cell lines were cultured on 6-well plates in
DMEM or DMEM containing 10 ng/ml NGF for 48 hr. The cells were
then trypsinized and washed once with DMEM/10% FCS and twice
with MT-PBS containing 2% FCS. A total of 10 6 cells were incubated in
100 ml of solution containing 20 ml of Annexin-V-Fluos labeling reagent
and 20 ml of 50 mg/ml propidium iodide solution in 1 ml of incubation
buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 5 mM CaCl2 ).
After 15 min of incubation, 200 ml of a HEPES and phosphate-buffered
balanced salt solution containing 5% FCS was added per tube, and the
cells were immediately analyzed on a flow cytometer for fluorescein and
propidium iodide detection.
Northern blotting. To confirm that the transfected clones were Schwann
cells, transcripts of the Schwann cell glycoprotein P0 gene in untrans-
fected and transfected Schwann cells were analyzed by Northern blotting,
using a 1.85 kb probe that recognizes the Schwann cell-specific P0 RNA.
The pSN63 plasmid containing the P0 cDNA insert was a gift from G.
Lemke (The Salk Institute, La Jolla, CA). Briefly, the P0 fragment was
cut from the SN63 vector with EcoRI digestion, gel-purified using a
QIAEX II gel extraction kit, and labeled with 32P using a NeBlot kit
(New England Biolabs, Beverly, MA). The labeled probe was hybridized
overnight at 68°C with Schwann cell mRNA previously transferred to a
Hybond-N membrane (Amersham). Images were developed after a 4 hr
exposure using a Phosphoimager (Molecular Dynamics, Sunnyvale, CA).
In addition, Northern blotting was used to determine expression of the
high-affinity NGF receptor Trk-A on the Bcl-2-transfected Schwann cell
lines. A 398 bp fragment of Trk-A cDNA, cloned into the pBSKS(2)
Figure 4. Survival of Bcl-2-transfected rat Schwann cells in vitro after survival factor withdrawal or treatment with either exogenous NGF or anti-NGF
antibodies. The control cells were transfected with the empty mammalian expression vector pEF. Cells were cultured in multiple microwell plates in (A)
DMEM only or (B, C) DMEM containing exogenous NGF or (D) anti-NGF antibody. The numbers of viable cells were assessed daily over a 3 d period.
A, Bcl-2 protects Schwann cells from apoptosis induced by survival factor withdrawal. The data shown represent means 6 SEM of three independent
experiments comparing the survival of three separate Bcl-2-transfected Schwann cell lines (Bcl-2#1, Bcl-2-#3, and Bcl-2#4 ) with the survival of a control
cell line, pEF. All three Bcl-2-transfected cell lines exhibited a significant survival advantage at 24, 48, and 72 hr ( p values from 0.005 to ,0.0005). B,
Nerve growth factor at 10 ng/ml significantly reduces the survival of Bcl-2-transfected Schwann cells. Means 6 SEM of three independent experiments
with Bcl-2#1 and -#3 cell lines and the control cell line pEF#1 are shown. p values are 0.001, 0.01, and 0.0025 for the Bcl-2#1 cell line and 0.025, 0.001,
and 0.1 (NS) for the Bcl-2#3 cell line at 24, 48, and 72 hr, respectively. C, Dose–response study of the effect of NGF on the survival of Bcl-2-transfected
Schwann cells. Shown are mean viabilities 6SEM of Bcl-2#1, Bcl-2#3, and Bcl-2#4 cell lines assayed in one survival experiment. Culture conditions
were either DMEM alone or DMEM with 1, 10, or 100 ng/ml of NGF. All three concentrations of NGF significantly reduced the survival of the
Bcl-2-transfected cell lines, the lower concentrations slightly but not significantly ( p . 0.05) more than 100 ng/ml. D, Anti-NGF antibody increases the
survival of Bcl-2-transfected Schwann cells. Shown are the means 6 SEM, comparing the viability of three separate Bcl-2-transfected cell lines assayed
in one survival experiment. Culture conditions were DMEM only, DMEM 1 10 ng/ml NGF, or DMEM 1 500 ng/ml anti-NGF antibody. The difference
in survival between DMEM only and anti-NGF conditions was significant at 48 hr ( p 5 0.025), and the difference between NGF-neutralized (anti-NGF)
and NGF-added conditions was significant at all time points ( p values from 0.001 to 0.005).
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vector was a gift from Dr. R. Klein (EMBL, Heidelberg, Germany). The
fragment was cut from the expression vector with EcoRI and XbaI
digestion and gel-purified using a QIAquick gel extraction kit. A total of
50 ng of purified DNA was labeled with 32P as described above and
hybridized overnight at 68°C with 0.5 mg of mRNA isolated from Bcl-2#1
cells and with 10 mg of total RNA from PC12 neuronal cells as a positive
control. Images were developed after a 72 hr exposure using a Phospho-
imager. To assess the amount of RNA loaded, the membrane was further
hybridized with a 280 bp G3PD (GAPDH)-probe, cut with PstI–HindIII
digestion from a pGEM3Z plasmid.
Western blotting. Reduced and denatured protein samples from control
and Bcl-2-transfected Schwann cells were run on a 4–15% SDS Tris-HCl
gel (Bio-Rad, Richmond, CA), transferred to a polyvinylidene difluoride
membrane, and blotted with Bcl-2–100 mAb. Bound antibodies were
detected with HRP-conjugated sheep anti-mouse IgG (Silenius) and
enhanced using chemiluminescence (Amersham).
RT-PCR. Degenerate primers amplifying a 549 bp fragment from the
coding region of exon 1 of the Rattus norveg icus Bcl-2 cDNA were
designed with the aid of NCBI’s Blast 2.0 sequence similarity search
program. The upper primer was 59-CGCAAGCCGGGAGAACAG-
GGTA-39, and the lower primer was 59-AGGTGTGCAGATGCC-
GGTTCAGGT-39. These primers were designed to maximize amplifi-
cation of sequences similar in the rat, mouse, and human Bcl-2 genes,
with minimal homology to other Bcl family members, and were synthe-
sized by Beckman Oligonucleotide Synthesis Service (Gladesville, NSW,
Australia). As a positive control, a 760 bp fragment of rat b-actin was
amplified using 59-CTGAAGTACCCCATTGAACACGGC-39 as the
upper primer and 59-CAGGGCAGTAATCTCCTTCTGCAT-39 as the
lower primer. The b-actin oligonucleotides were also designed using the
Blast 2.0 computer program, and they were synthesized by Pacific Oligos
(Southern Cross University Lismore, NSW, Australia).
To synthesize first-strand DNA for RT-PCR, total RNA (1 mg) or
mRNA (50 ng) isolated from wild-type rat Schwann cells was reverse-
transcribed using Superscript II RNase H 2 Reverse Transcriptase (Life
Technologies) in a 20 ml reaction volume at 42°C. The various culture
conditions from which RNA had been prepared were as follows: (1)
DMEM containing 10% FCS, 10 ng/ml neuregulin-b, and 2 mM forsko-
lin, (2) DMEM containing IGF-1 for either 4 or 16 hr, (3) DMEM
containing NGF for 4 hr, (4) DMEM only for 1, 2, 4, 8, or 24 hr. For
RT-PCR, 5% (1 ml) of the first-strand reaction was amplified in a reaction
containing 0.4 ml of 10 mM dNTP mixture (Life Technologies), 1 ml of
each primer at 20 mM, 1 ml of 50 mM MgCl2 , 5 ml of 103 PCR buffer (Life
Technologies), and 0.5 ml (2.5 U) of AmpliTag (Perkin-Elmer, Em-
eryville, CA) to a total volume of 50 ml. A total of 30 cycles of PCR
amplification was performed on a Perkin-Elmer Cetus 480 thermal cycler
(Perkin-Elmer) at 94° for 1 min, 58° for 1 min, and 72° for 2 min.
Reaction products were electrophoretically separated on a 2% DNA
grade agarose gel containing 5 mg/ml ethidium bromide stain to facilitate
visualization of the bands under UV illumination.
RESULTS
Generation and characterization of Bcl-2- and CrmA-
expressing Schwann cell lines
To assess the effect of Bcl-2 and CrmA on Schwann cell survival
we transfected primary rat Schwann cells with puromycin-
selectable constructs containing sequences encoding FLAG
epitope-tagged human Bcl-2 or FLAG-tagged CrmA. Expression
of the constructs in the stable puromycin-resistant rat Schwann
cell lines that were generated was demonstrated by intracellular
immunofluorescence staining with anti-human Bcl-2 antibodies
or, in the case of the CrmA transfected cells, with anti-Flag-
antibodies. Three Bcl-2-transfected and three CrmA-transfected
cell lines that expressed high and similar levels of Bcl-2 and
CrmA, respectively, were chosen for further experiments (Fig. 1).
To confirm that the transfected cell lines had retained Schwann
cell characteristics, all cell lines were assessed by immunohisto-
chemistry for expression of the glial protein S-100. All of the
transfected cell lines that were used in subsequent experiments
expressed S-100. Bcl-2#1 and CrmA#14 cell lines staining posi-
tively for S-100 are shown in Figure 2. Northern blotting was used
to confirm expression of the Schwann cell-specific P0 gene
(Lemke and Axel, 1985). P0 was expressed in all three Bcl-2-
transfected cell lines that were studied as well as in wild-type rat
Schwann cells but not in rat fibroblasts that were included as a
negative control (Fig. 3).
Bcl-2 rescues Schwann cells from apoptosis triggered
by withdrawal of survival factors but fails to rescue
these cells from killing by NGF
To elucidate the potential role of Bcl-2 in Schwann cell apoptosis,
we assessed the viability of three separate Bcl-2-transfected rat
Schwann cell lines in comparison with rat Schwann cell lines
transfected with the empty mammalian expression plasmid pEF
FLAGpGKpuro (pEF). The first death stimulus that was assessed
was withdrawal of serum, neuregulin-b, and forskolin. All three
Bcl-2-transfected cell lines exhibited significant survival advan-
tage at 24, 48, and 72 hr after factor deprivation in comparison
with the pEF#1 control cell line (Fig. 4A). Survival of the pEF#1
and pEF#2 control cell lines used in this study did not signifi-
cantly differ from wild-type Schwann cells (data not shown).
The survival factor-starved Bcl-2-transfected cells were also
cultured with NGF at the time of plating. Addition of NGF at 10
ng/ml to the cultures reduced the viability of all three Bcl-2-
transfected cell lines throughout the 72 hr observation period
(Fig. 4B). There was a trend toward more cell death at the lower
concentrations of NGF (1 and 10 ng/ml) than at 100 ng/ml, but
Figure 5. Nerve growth factor does not induce cleavage of Bcl-2. West-
ern blotting of Bcl-2-transfected and control Schwann cells was performed
to determine whether NGF induces cleavage of Bcl-2. Lane 1, Wild-type
rat Schwann cells; lane 2, Bcl-2-transfected Schwann cells in serum,
neuregulin-b, and forskolin; lanes 3 and 4, survival factor-deprived con-
dition for 24 hr; lanes 5 and 6, survival factor-deprived condition for 72 hr.
No cleavage product was detected when 10 ng/ml NGF was present in the
survival factor-deprived conditions (lanes 4 and 6 ).
Table 1. Bcl-2-transfected Schwann cells are resistant to apoptosis
induced by survival factor deprivation but undergo apoptosis in
response to NGF
PI2 (%) PI1 (%) Annexin1 (%)
pEF 2 NGF 1 98 98
pEF 1 NGF 7 92 96
Bcl-2#1 2 NGF 92 7 13
Bcl-2#1 1 NGF 67 32 33
Control (pEF) and Bcl-2-transfected Schwann cells were deprived of serum,
neuregulin-b, and forskolin for 48 hr. NGF (10 ng/ml) was added to half of the
cultures. To determine the proportions of viable and apoptotic cells in each condi-
tion, the cells were detached and stained at 48 hr with propidium iodide (PI) and
Annexin-V-Fluos solution and analyzed by flow cytometry. Viable cells exclude
propidium iodide and appear in the table as PI2. The data are generated from a
single experiment.
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the differences in viability between the various concentrations
were not statistically significant (Fig. 4C). Viability of the vector-
only pEF#1 cells was not significantly affected by the addition of
NGF under conditions of survival factor deprivation, presumably
because these cells were dying so rapidly (data not shown).
To quantitate viability, the survival factor-deprived and the
NGF-treated Schwann cells were stained with Annexin, which
labels apoptotic cells, and the cells were analyzed by flow cytom-
etry (Table 1). After withdrawal of survival factors, most (98%)
of the control cells were Annexin positive at 48 hr, whereas only
13% of the Bcl-2#1 Schwann cells were Annexin positive. How-
ever, 33% of the survival factor-deprived Bcl-2#1 Schwann cells
cultured with NGF were Annexin positive at 48 hr (Table 1). This
correlated well with the survival advantage conferred by Bcl-2
and with the killing observed by NGF in the context of Bcl-2
expression, as assessed in the MTT assays.
Because Schwann cells have been reported to secrete low levels
of NGF (Yamamoto et al., 1993), we next assessed the effect of
neutralizing anti-NGF antibodies on the survival of the Bcl-2-
transfected Schwann cells. Previously, it had been established that
exogenous NGF and anti-NGF antibodies have no effect on the
viability of wild-type Schwann cells in basal conditions after
Figure 6. Survival analysis of CrmA-
transfected rat Schwann cells in vitro after
survival factor withdrawal or treatment
with exogenous NGF. A, CrmA-trans-
fected cells show delayed but retained sus-
ceptibility to survival factor deprivation
but are protected against NGF killing.
Shown are the mean viabilities 6SEM of
three separate CrmA-transfected Schwann
cell lines (CrmA#7, #14, and #15) in
comparison with the pEF#1 control cell
line, as assessed in one of two similar sur-
vival experiments. Cell lines were cultured
either in DMEM only or in DMEM con-
taining 10 ng/ml NGF. Control pEF cells
died rapidly in both conditions (only
DMEM is shown). CrmA-transfected cells
showed some abrogated death at 24 hr
( p 5 0.025), but by 72 hr both the CrmA
and control cells showed a similar death
profile ( p values 0.1 at 48 hr and 0.15 at 72
hr; NS). B, CrmA-transfected cells are re-
sistant to NGF killing in the presence of
IGF-1, whereas Bcl-2-transfected Schwann
cells remain susceptible to NGF under
these conditions. Shown are means 6 SEM
of three separate experiments using the
cell lines Bcl-2#1 and CrmA#7. The cells
were cultured in either DMEM containing
100 ng/ml IGF-1 or DMEM containing
100 ng/ml IGF-1 and 10 ng/ml NGF. The
difference in survival between the two cul-
ture conditions was significant for the Bcl-
2#1 cell line ( p values from 0.025 to
0.005), but not for the CrmA#7 cell line
( p . 0.05).
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growth factor withdrawal (T. J. Kilpatrick, unpublished observa-
tion). We found that blocking the NGF activity increased the
survival of all three growth factor-deprived Bcl-2-transfected cell
lines by 20–25% (Fig. 4D). At 48 hr the survival of Bcl-2-
transfected Schwann cells that were treated with anti-NGF anti-
bodies was almost 100% and significantly higher than the survival
of untreated cells. The difference in survival between cultures
treated with exogenous NGF and those in which endogenous
NGF activity was neutralized was ;50% (Fig. 4D).
NGF does not lead to cleavage of Bcl-2 in
Schwann cells
To determine whether cleavage of Bcl-2 could be involved in the
NGF-induced killing of the Bcl-2-expressing Schwann cells, we
prepared Western blots of Bcl-2-transfected Schwann cells. The
Schwann cells were cultured with either serum, neuregulin-B, and
forskolin or, alternatively, without these additives, either with or
without NGF, for 24 or 48 hr. We used the same anti-human Bcl-2
100 antibody that was used for recognition of the cleaved 23 kDa
fragment by Cheng et al. (1997). The antibody specifically recog-
nized the 28 kDa noncleaved human Bcl-2 protein in the Bcl-2-
transfected cells but, as expected, not endogenous Bcl-2 in the
wild-type rat Schwann cells (Fig. 5). No cleavage of Bcl-2 was
demonstrated (Fig. 5, lanes 4 and 6).
CrmA delays but does not inhibit apoptosis triggered
by survival factor withdrawal but protects against
killing by NGF
The effects of growth factor withdrawal and of exogenous NGF
on the viability of CrmA-transfected Schwann cells were also
assessed. The CrmA-transfected cell lines showed some potenti-
ated survival in comparison to control cells at 24 hr after with-
drawal of survival factors, but by 72 hr they showed a proportion
of cell death similar to that of control cultures (Fig. 6A). Nerve
growth factor did not decrease the survival of the growth factor-
deprived CrmA-transfected Schwann cells (Fig. 6A). To exclude
the possibility that the death signal induced by survival factor
withdrawal masked killing of the CrmA-transfected Schwann cells
triggered by NGF, assays were also performed in the presence of
IGF-1 to potentiate the baseline survival of the CrmA-transfected
population. CrmA-transfected cells were also protected against
NGF killing in these conditions (Fig. 6B), whereas Bcl-2-
transfected cells remained susceptible to NGF in the presence of
IGF-1 (Fig. 6B).
Wild-type Schwann cells are susceptible to killing by
NGF in the presence of survival factors
Survival factor-deprived wild-type rat Schwann cells died rapidly,
and their survival was not significantly affected by NGF (Fig. 7).
Because a death signal induced by NGF could not be assessed in
cells that were already dying, we established conditions in which
wild-type Schwann cells survived, but did not proliferate, by
culturing them with IGF-1 and neuregulin-b. In these conditions,
addition of 10 ng/ml exogenous NGF decreased the viability of
wild-type Schwann cells by ;30% (Fig. 7). Thus, the susceptibil-
Figure 7. Wild-type rat Schwann cells
undergo apoptosis after survival factor
deprivation, with no significant differ-
ence in viability with or without NGF
( p . 0.05). However, 10 ng/ml NGF
significantly decreases Schwann cell via-
bility when the cells are cocultured with
IGF-1 and neuregulin-b. Means 6 SEM
of three separate experiments are shown.
The differences in survival between IGF-
11GGF and IGF-11GGF1NGF condi-
tions were significant at all time points
assessed ( p values 0.05, 0.025, and 0.005
at 24, 48, and 72 hr, respectively).
Figure 8. Transcripts of the high-affinity NGF receptor TrkA are not
detectable in the Bcl-2-transfected Schwann cells. Northern blots were
prepared using mRNA (;0.5 mg/ lane) isolated from Bcl-2#1 Schwann
cells cultured in DMEM containing 10 ng/ml NGF for 4 hr (lane 1) or on
survival factor withdrawal for 4 hr (lane 2) or in DMEM containing
serum, neuregulin-b, and forskolin (lane 3). Approximately 10 mg of total
RNA isolated from PC12 neuronal cells was loaded as a positive control
in lane 5. The arrow indicates the TrkA transcript between the 28S and
18S ribosomal RNA bands that was detected in RNA isolated from the
PC12 cells.
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ity of wild-type Schwann cells to NGF was similar to the suscep-
tibility of the Bcl-2-transfected Schwann cells, once no other
interfering death stimuli were operative.
Expression of NGF receptors by the transfected
Schwann cell lines
The induction of wild-type Schwann cell death by NGF was likely
to have been mediated by p75, because these cells have not been
shown to express TrkA but they express high levels of p75 (Lemke
and Chao, 1988; Yamamoto et al., 1993). To determine whether
the NGF-mediated effects in the Bcl-2-transfected rat Schwann
cell lines were mediated by p75, we assessed expression of TrkA
by these cells by Northern blotting. No TrkA message was detect-
able in Bcl-2-transfected Schwann cells cultured for 4 hr in
DMEM containing serum, neuregulin-b, and forskolin, in
DMEM alone, or in DMEM containing 10 ng/ml of NGF (Fig.
8). Expression of p75 was assessed by indirect immunofluores-
cence staining and flow cytometry. All of the cell lines expressed
p75, with the CrmA lines appearing to express the receptor at the
highest level (Fig. 9).
p75-deficient Schwann cells are resistant to killing
by NGF
To establish whether NGF-mediated Schwann cell death required
p75, we generated Schwann cell cultures from mice homozygous
for a deletion in the p75 gene and from wild-type control mice.
Unlike the wild-type rat Schwann cells that had been passaged
several times in vitro, ;25% of the wild-type mouse Schwann cells
(second to third passage) survived 48 hr without serum or
neuregulin-b, and their survival was significantly decreased by
NGF added at the time of plating (Fig. 10) ( p , 0.0005). In
contrast, the Schwann cells isolated from p75 knockout mice were
completely resistant to NGF killing (Fig. 10). As we have shown
before (our unpublished results), the p75-deficient Schwann cells
also exhibited a survival advantage in comparison with the wild-
type mouse Schwann cells on survival factor deprivation (Fig. 10).
Expression of the Bcl-2 gene is regulated by wild-type
Schwann cells
Regulation of Bcl-2 expression in wild-type rat Schwann cells was
studied using RT-PCR. Bcl-2 mRNA was expressed in all culture
conditions that promoted survival, including IGF-1 alone,
throughout the 16 hr assay period (Fig. 11). In contrast, after 2 hr
of serum, neuregulin-b, and forskolin withdrawal, Bcl-2 mRNA
expression was downregulated to an undetectable level (Fig. 11).
However, when NGF was present in the media, after the with-
drawal of serum and other survival factors, Bcl-2 could be still
detected at 4 hr, suggesting that NGF, at least in the short term,
maintained Bcl-2 expression (Fig. 11).
DISCUSSION
Rat Schwann cell lines that stably express either human Bcl-2 or
a poxvirus caspase inhibitor, CrmA, were used to investigate the
Figure 9. Bcl-2-transfected, CrmA-transfected, and control rat Schwann cells express the low-affinity NGF receptor p75 on the cell surface.
Approximately 10 6 pEF, Bcl-2#1, Bcl-2#3, Bcl-2#4, CrmA#7, or CrmA#14 cells were stained with mAb MC192 against the rat p75 receptor or with
mouse IgG1 control mAb, followed by FITC-conjugated sheep anti-mouse IgG. Fluorescence was measured using a flow cytometer. The background
fluorescence obtained with the isotype-matched control mAb (dotted lines) was subtracted from the total pool to enable calculation of the percentages
of cells from each cell line that expressed p75 (labeled as the M1 population).
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mechanisms that effect Schwann cell survival in response to
different death stimuli, either survival factor deprivation or a
stimulus initiated by NGF, signaling through its low-affinity re-
ceptor p75. The results indicated that Bcl-2 protected Schwann
cells from apoptosis induced by survival factor deprivation,
whereas CrmA did not. This is consistent with previously estab-
lished differential roles for Bcl-2 and CrmA as inhibitors of
apoptosis: Bcl-2 blocks apoptosis induced by a wide variety of
insults, apparently acting by inhibiting adaptors required for
activation of certain caspases such as caspase 9 (Strasser et al.,
1995; Adams and Cory, 1998), whereas CrmA appears to be more
effective in blocking TNF family receptor-mediated apoptosis, by
inhibiting caspase 8 (Smith et al., 1996; Ashkenazi and Dixit,
1998). Our results confirm a functional dichotomy in the regula-
tion of Schwann cell death into Bcl-2 inhibitable and CrmA-
inhibitable death pathways, although the death of neurons after
deprivation of NGF is blockable by either Bcl-2 (Park et al., 1996)
or CrmA (Gagliardini et al., 1994). It is thus possible that the
pathways of cell death initiated by loss of trophic support are
different in Schwann cells and neurons. This is consistent with
emerging in vivo data that suggest coexistence of several different,
not only stimulus-specific but also cell type-specific, apoptotic
pathways in mammalian cells (Hakem et al., 1998).
Several neuronal cell types die in response to NGF, including
sensory dorsal root ganglion neurons (Barrett and Bartlett, 1994),
neuronal precursors in embryonic chicken retina (Frade et al.,
1996), and cholinergic forebrain neurons (Van der Zee et al.,
1996). In at least three instances, this mechanism has been dem-
onstrated to contribute to developmentally regulated death of
neurons in vivo (Frade et al., 1996; Van der Zee et al., 1996; Bamji
et al., 1998). In addition, mature oligodendrocytes that express
p75, but not TrkA, are susceptible to NGF-induced cell death,
whereas oligodendrocyte precursors and astrocytes are resistant
(Casaccia-Bonnefil et al., 1996). Similarly, the Bcl-2-transfected
Schwann cell lines that we have analyzed did not express TrkA
mRNA (Fig. 8), whereas p75 was expressed at high levels (Fig. 9).
The effect of p75 activation, however, is almost certainly contex-
tural, as demonstrated by the resistance of the CrmA-transfected
Schwann cells to killing by NGF (Fig. 6A). CrmA is quite selec-
tive in its ability to inhibit caspases, showing the highest affinities
to caspase 1 (interleukin-1b converting enzyme) and caspase 8
(Zhou et al., 1997; Garcia-Calvo et al., 1998). Therefore, activa-
tion of caspase 1 or caspase 8 or both, in addition to expression of
p75 in the absence of TrkA, is likely to be necessary for induction
of cell death by NGF. High levels of the Bcl-2 transgene expressed
in Schwann cells, or alternatively, culture of wild-type Schwann
cells in conditions that maintained their viability and Bcl-2 ex-
pression, were permissive for killing induced by exogenous NGF,
suggesting that NGF was killing via a Bcl-2-independent pathway.
Schwann cells isolated from mice lacking a functional p75 recep-
tor were resistant to the NGF-induced cell death, corroborating
that the NGF killing was mediated by p75.
Schwann cells secrete NGF (Lindholm et al., 1987), and we
found that inhibition of endogenous NGF activity resulted in a
significant increase in the viability of survival factor-deprived
Bcl-2-transfected Schwann cells. This suggests that incomplete
protection of the Bcl-2-transfected Schwann cells against survival
factor deprivation was caused by death induced by endogenous
NGF. Death-inducing activity of endogenous NGF could also
explain the observed inferior survival of wild-type mouse
Schwann cells in comparison with the p75-deficient mouse
Schwann cells after survival factor deprivation (Fig. 10). More-
over, our results argue against a role for constitutive death-
inducing activity of p75 in the absence of ligand binding (Rabi-
zadeh et al., 1993) in this lineage, because prevention of ligand
binding increased survival rather than induced death.
The Bcl-2 family is regulated by cytokines and other death/
survival signals (Adams and Cory, 1998). Using RT-PCR we
confirmed that wild-type Schwann cells express Bcl-2 mRNA. We
also demonstrated early downregulation of Bcl-2 transcript ex-
pression in Schwann cells after survival factor deprivation (Fig.
11). This supports a role for Bcl-2 in the maintenance of Schwann
cell viability induced by survival factors. Detailed analysis of the
nervous systems of Bcl-22/2 mice has indicated progressive loss
of neurons during early postnatal development, but the effects on
Schwann cell numbers ensheathing surviving neurons or the
effects on Schwann cell survival after axotomy remain unexplored
(Michaelidis et al., 1996). Preliminary experiments using ribonu-
clease protection assays have suggested that Bcl-2 is indeed ex-
pressed by postnatal Schwann cells in wild-type animals both in
the quiescent state and after axotomy (D. Syroid and G. Lemke,
unpublished observations). Further analyses of these expression
patterns will form the basis for understanding the potential phys-
iological relevance of Bcl-2 as a modulator of Schwann cell
survival.
Previously, it has been established that axotomy leads to po-
tentiated apoptosis among Schwann cells deprived of axonal
contact (Grinspan et al., 1996; Syroid et al., 1996). If Bcl-2 were
upregulated after nerve injury in response to cytokines released
at the lesion site (Creange et al., 1997), this would facilitate the
survival of Schwann cells in the distal stump. Downregulation of
Figure 10. Schwann cells isolated from p75 knockout mice are resistant
to NGF killing, whereas wild-type mouse Schwann cells are susceptible.
The viability of Thy-1.2-sorted, p75 2/2 and p75 1/1 Schwann cells was
assessed at 48 hr after FCS and neuregulin-b withdrawal, with or without
10 ng/ml NGF. Shown is the mean viability 6SEM of cells cultured in six
parallel wells for each condition as assessed in one of two survival
experiments, each with similar results.
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Bcl-2 expression by Schwann cells that completely lose access to
axonally derived neuregulins (Grinspan et al., 1996) and IGF-1
(Syroid et al., 1999) would increase their susceptibility to
apoptosis.
Our results also suggest an alternative mechanism by which the
cells could die. Schwann cells upregulate their p75 expression and
production of NGF after axotomy (Lindholm et al., 1987; Lemke
and Chao, 1988; Taniuchi et al., 1988). This could facilitate the
presentation of NGF to regenerating axons (Taniuchi et al.,
1988). In this context, Schwann cells that fail to make a viable
contact with the regenerating axons and subsequently fail to
present NGF to them could be eliminated via continued activa-
tion of p75, even if Bcl-2 expression is maintained. Early and
robust invasion of macrophages is also a feature in peripheral
nerve injury and has been hypothesized to contribute to periph-
eral nerve degeneration (Franzen et al., 1998). Macrophages, like
Schwann cells, can release NGF, and it is of note that microglia-
derived NGF induces apoptosis in embryonic chick retinal neu-
rons (Frade et al., 1996; Frade and Barde, 1998). Thus it is
possible that infiltrating macrophages contribute to the induction
of Schwann cell death. This could be useful in the killing of
supernumerary Schwann cells, but if unchecked could lead to
excessive cell death and thus limit peripheral nerve repair. A
potential role of NGF in mediating Schwann cell death could have
important implications for the ongoing clinical trials in which
NGF is being assessed as a potential therapeutic agent for pe-
ripheral neuropathies (Rogers, 1996; Apfel et al., 1998).
Little is known about the intracellular pathways that mediate
p75-induced apoptosis, although the molecular events that signal
downstream of the related molecule TNFR have been investi-
gated extensively (Ashkenazi and Dixit, 1998). Regulation of
transcription factor expression is likely to be implicated, because
inhibition of both NF-kB and JNK/AP1 pathways sensitizes cells
to apoptosis induced by TNF (Beg and Baltimore, 1996; Roulston
et al., 1998). Moreover, aspartyl-glutamyl-valyl-aspartyl (DEVD)-
specific caspases appear to participate in TNF-mediated apopto-
sis only when NF-kB is inhibited (Wang et al., 1998). Overex-
pression of Bcl-2 in PC12 neuronal cells has been shown to block
JNK activation caused by growth factor withdrawal (Park et al.,
1996). It remains to be investigated whether blockade of JNK (or
NF-kB) also occurs in Bcl-2-expressing Schwann cells and
whether this inhibition increases the susceptibility to p75-
mediated cell death.
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